Role of aromatase inhibitors in managing hypogonadism in adult males related to obesity and aging: A systematic review and meta-analysis

Role of aromatase inhibitors in managing hypogonadism in adult males related to obesity and aging: A systematic review and meta-analysis

No meta-analysis is available which has analysed the role of aromatase inhibitors (AIs) in hypogonadism in adult males related to obesity and aging. This meta-analysis intended to address this knowledge gap. Electronic databases were searched for studies involving adult males with hypogonadism. The...

Full description

Bibliographic Details
Main Authors:	Deep Dutta, Ritin Mohindra, Manoj Kumar, Meha Sharma
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	aging anastrozole aromatase inhibitors letrozole male hypogonadism meta-analysis obesity safety
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=6;spage=501;epage=509;aulast=Dutta

Similar Items

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
by: Javier García-Sánchez, et al.
Published: (2022-07-01)

Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
by: Cristina Ferreira Almeida, et al.
Published: (2023-04-01)

The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy
by: Nahid Punjani, MD, MPH, et al.
Published: (2021-08-01)

Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene Citrate
by: Sorena Keihani, et al.
Published: (2020-10-01)

A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility
by: Francesco Del Giudice, et al.
Published: (2020-01-01)

Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
by: Yoshihito Morimoto, et al.
Published: (2017-11-01)

The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue
by: D. V. Lytkin, et al.
Published: (2018-08-01)

Aromatase inhibitors in male sex
by: Santosh Kumar Singh
Published: (2013-01-01)

A radiation recall phenomenon induced by aromatase inhibitors
by: Sabrine Slimani, et al.
Published: (2021-03-01)

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
by: Georgia Colleluori, et al.
Published: (2020-05-01)

Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis
by: Bálint Bérczi, et al.
Published: (2024-03-01)

Interaction of Zinc Chloride with an Aromatase Inhibitor (Letrozole) on Anxiety in Adult Male Rats
by: Sahar Charghan, et al.
Published: (2016-12-01)

Aromatase inhibitors in the treatment of deep endometriosis
by: Simone Ferrero, et al.
Published: (2009-09-01)

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022-03-01)

Effect Of A Non-Steroidal Aromatase Inhibitor On Ovarian Function And Synchronicity Of Estrus In Ewes At Subtropics
by: Abdel Dayem M. A., et al.
Published: (2020-10-01)

Effect of Letrozole Administration as a Selective Aromatase Inhibitor on Male Rat's Reproductive Performance
by: A Hmood Jassim, et al.
Published: (2022-02-01)

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
by: Yoo Jung Kim, et al.
Published: (2020-01-01)

The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
by: Alessandra Linardi, et al.

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
by: Fionnuala Crowley, et al.
Published: (2022-04-01)

Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients
by: Manuela Vasquez Cardoso, et al.
Published: (2023-04-01)

Oral lichen sclerosus in a breast cancer patient on anastrozole therapy: A case report with brief review of literature
by: Chaturbhuj Agrawal, et al.
Published: (2017-01-01)

<i>In Vitro</i> Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
by: Patrícia H. A. Bezerra, et al.
Published: (2023-06-01)

EVALUATION OF LETROZOLE THERAPEUTIC EFFECT IN INFERTILE WOMEN
by: F. Akbary-Asbagh, et al.
Published: (2007-06-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
by: María Molina-Vega, et al.
Published: (2018-01-01)

Testis morphology in rats chronically treated with letrozole, an aromatase inhibitor
by: Lidia Wenda-Różewicka, et al.
Published: (2012-01-01)

The Role of Aromatase Inhibitors in Male Prolactinoma
by: Amit Akirov, et al.
Published: (2023-02-01)

Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?
by: Barbara Gardella, et al.
Published: (2021-02-01)

Effects of Letrozole Treatment and Vitamin C Supplementation on Morphology, Endoplasmic Reticulum Stress, Programmed Cell Death, and Oxidative Stress in the Small Intestine of Adult Male Rats
by: Anna Pilutin, et al.
Published: (2024-03-01)

Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis
by: Rashidra R. Walker, et al.
Published: (2022-03-01)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
by: Maurizio Nordio, et al.
Published: (2021-11-01)

Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis
by: Xing Huang
Published: (2019-11-01)

Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
by: Sandro La Vignera, et al.
Published: (2023-01-01)

The effect of anastrozol on spatial memory in adult rats
by: Hodosy Július, et al.
Published: (2009-06-01)

Normogonadotropic hypogonadism in men with obesity
Published: (2009-09-01)

Aromatase inhibitors in the treatment of endometriosis
by: Radosław Słopień, et al.
Published: (2016-03-01)

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial
by: Pamela M. J. McLaughlin, et al.
Published: (2022-05-01)

Molecular Docking of Aromatase Inhibitors
by: Virapong Prachayasittikul, et al.
Published: (2011-04-01)

Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor
by: Melissa Schwartz, et al.
Published: (2016-01-01)

Switching of Hormone Therapies in Breast Cancer Women
by: Luana Moreira de Medeiros, et al.
Published: (2021-05-01)

Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
by: Tara Hyder, et al.
Published: (2021-07-01)